"Insulin secretion is directly related to NASH, fibrogenesis and fibrosis in Non-diabetic patients with Non-Alcoholic Fatty Liver Disease"

Poster presentation given by UNITO, NB & CNR at the AASLD Liver Meeting, San Francisco, USA, 9th - 13th November 2018

"Clinical Characteristics and Long-Term Outcomes of Lean Caucasian Patients with Non-Alcoholic Fatty Liver Disease. A Longitudinal International Study"

Poster presentation given by UNITO, UNEW & CNR at the AASLD Liver Meeting, San Francisco, USA, 9th - 13th November 2018

Oral presentation given by UMC at the AASLD Liver Meeting, San Francisco, USA, 9th - 13th November 2018

"Severity of NAFLD/NASH is associated with both more severe β-cell dysfunction and reduced insulin clearance independently of body weight in a large cohort of nondiabetic subjects: further insights in the causative role of NASH in T2DM development"

Oral presentation given by CNR at the AASLD Liver Meeting, San Francisco, USA, 9th - 13th November 2018

"Altered lipid metabolism in obesity, non-alcoholic fatty liver disease and the associated co-morbidities"

Oral presentation given by ORU at the 2nd International Symposium on Lipid Science and Health, Qingdao, China, 4th November 2018

Invited oral presentation given by UNITO at the 26th UEG Week, Vienna, Austria, 22nd October 2018

Oral presentation given by UNEW at the EASL NAFLD Summit, Geneva, Switzerland, 21st September 2018

Oral presentation given by UNEW at AASLD/EASL NAFLD Endpoints Conference, Alexandria, VA, USA, 30th June 2018

Oral presentation given by UMC at the EASL NAFLD Summit, Geneva, Switzerland, 21st September 2018

Oral presentation given by CNR at the EASL NAFLD Summit, Geneva, Switzerland, 21st September 2018